EGFL8 anticorps (C-Term)
Aperçu rapide pour EGFL8 anticorps (C-Term) (ABIN630151)
Antigène
Voir toutes EGFL8 AnticorpsReactivité
Hôte
Clonalité
Conjugué
Application
-
-
Épitope
- C-Term
-
Specificité
- EGFL8 antibody was raised against the C terminal of EGFL8
-
Purification
- Purified
-
Immunogène
- EGFL8 antibody was raised using the C terminal of EGFL8 corresponding to a region with amino acids QAGAWVRAVLPVPPEELQPEQVAELWGRGDRIESLSDQVLLLEERLGACS
-
-
-
-
Indications d'application
-
WB: 1.25 µg/mL, IHC: 4-8 µg/mL
Optimal conditions should be determined by the investigator. -
Commentaires
-
EGFL8 Blocking Peptide, (ABIN5613316), is also available for use as a blocking control in assays to test for specificity of this EGFL8 antibody
-
Restrictions
- For Research Use only
-
-
-
Format
- Lyophilized
-
Reconstitution
- Lyophilized powder. Add distilled water for a 1 mg/mL concentration of EGFL8 antibody in PBS
-
Concentration
- Lot specific
-
Buffer
- PBS
-
Conseil sur la manipulation
-
Avoid repeated freeze/thaw cycles.
Dilute only prior to immediate use. -
Stock
- 4 °C/-20 °C
-
Stockage commentaire
- Store at 2-8 °C for short periods. For longer periods of storage, store at -20 °C.
-
-
- EGFL8 (EGF-Like-Domain, Multiple 8 (EGFL8))
-
Autre désignation
- EGFL8
-
Sujet
- The function of EGF protein is not widely studied, and is yet to be elucidated fully.
-
Poids moléculaire
- 32 kDa (MW of target protein)
Antigène
-